Transcutaneous Spinal Cord Stimulation in Healthy Adults

Launched by SHIRLEY RYAN ABILITYLAB · Oct 30, 2023

Keywords

ClinConnect Summary

This clinical trial is designed to explore how a treatment called transcutaneous spinal cord stimulation (tSCS) affects muscle activity in the legs and how comfortable participants feel during the process. The study will look at different settings of the tSCS, such as where it is applied on the body and how often it is adjusted. The researchers aim to understand the best way to use this treatment in healthy adults.

To participate in the trial, individuals must be between 18 and 75 years old and able to provide written consent. However, people with certain health conditions—like a history of stroke, pregnancy, or serious skin issues—will not be eligible. Participants can expect to engage in the study procedures and contribute to important research that could lead to better treatments in the future. This study is not currently recruiting but aims to provide valuable insights into how this stimulation technique can be used safely and effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-75 years old
• • Able and willing to give written consent and comply with study procedures
• Exclusion Criteria:
• • History of stroke or neurologic pathologies (such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, etc.)
• • Pregnant or nursing
• • Skin allergies or irritation; open wounds
• • Utilizing a powered, implanted cardiac device for monitoring or supporting heart function (i.e. pacemaker, defibrillator, or LVAD)
• • History of seizures or epilepsy
• • Active cancer or cancer in remission less than 5 years
• • Metal implants in the back or spine
• • Painful musculoskeletal dysfunction due to injury or infection
• • Unstable cardiorespiratory or metabolic diseases (e.g. cardiac arrhythmia, uncontrolled hypertension, uncontrolled diabetes, or chronic emphysema)